Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Maze Therapeutics, Inc. market cap for the quarter ending 2026-08-05 was $1.54B, a 147.39% increase year-over-year.
Maze Therapeutics, Inc. market cap for the quarter ending 2026-06-30 was $1.66B, a 203.91% increase year-over-year.
Maze Therapeutics, Inc. market cap for the quarter ending 2026-05-07 was $1.41B, a 221.34% increase year-over-year.
Maze Therapeutics, Inc. market cap for the quarter ending 2026-03-31 was $1.48B, a 207.07% increase year-over-year.
Maze Therapeutics, Inc. market cap for fiscal 2026 was $1.54B.
Maze Therapeutics, Inc. market cap for fiscal 2025 was $2.05B.